Literature DB >> 20599825

HCNP precursor protein transgenic mice display a depressive-like phenotype in old age.

Noriyuki Matsukawa1, Yoshiaki Furuya, Hiroo Ogura, Kosei Ojika.   

Abstract

We have previously reported a novel peptide, hippocampal cholinergic neurostimulating peptide (HCNP), which induces acetylcholine synthesis by increasing the amount of cholineacetyltransferase (ChAT) in medial septal nuclei. The HCNP precursor protein, composed of 186 amino acids, is an inhibitory factor of the c-Raf/ MEK cascade and may be involved in the development of the fetal rat brain via the inhibition of Erk phosphorylation. To clarify the involvement of HCNP in hippocampal cholinergic circuitry, we previously generated HCNP precursor protein (HCNP-pp) transgenic mice using the promoter of the alpha subunit of Ca(2+) calmodulin-dependent protein kinase II (CaMKIIalpha). These mice showed increased levels of ChAT in medial septal nuclei. Here, we investigated the behavioral phenotype of these mice, such as locomotor activity, mood and working/spatial memory. We demonstrate that HCNP-pp transgenic mice show a depressive-like phenotype at 30 weeks of age, but not at 12 weeks of age. We suggest that either HCNP and/or HCNP precursor protein may evoke the depressive-like phenotype via cholinergic hyperactivity from early neonatal life and/or inhibition of phosphorylated Erk in the neonatal hippocampus. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599825     DOI: 10.1016/j.brainres.2010.06.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression.

Authors:  Sabrina Bassi; Marianne L Seney; Pablo Argibay; Etienne Sibille
Journal:  J Psychiatr Res       Date:  2015-02-20       Impact factor: 4.791

Review 2.  Raf kinase inhibitory protein (RKIP): functional pleiotropy in the mammalian brain.

Authors:  Harrod H Ling; Lucia Mendoza-Viveros; Neel Mehta; Hai-Ying M Cheng
Journal:  Crit Rev Oncog       Date:  2014

Review 3.  The unsolved mystery of hippocampal cholinergic neurostimulating peptide: A potent cholinergic regulator.

Authors:  Justin Y Cho; Noriyuki Matsukawa
Journal:  Brain Circ       Date:  2021-03-30

4.  Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice.

Authors:  Yuta Madokoro; Yuta Yoshino; Daisuke Kato; Toyohiro Sato; Masayuki Mizuno; Tetsuko Kanamori; Masamitsu Shimazawa; Hideki Hida; Hideaki Hara; Mari Yoshida; Cesario V Borlongan; Kosei Ojika; Noriyuki Matsukawa
Journal:  Int J Mol Sci       Date:  2019-10-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.